Vitamin D Testing Market in the US 2015-2019
|出版商||TechNavio (Infiniti Research Ltd.)||商品編碼||347970|
|出版日期||內容資訊||英文 72 Pages
|美國的維他命D檢驗市場 (2015∼2019年) Vitamin D Testing Market in the US 2015-2019|
|出版日期: 2015年12月23日||內容資訊: 英文 72 Pages||
一般認為美國國內的維他命D檢驗市場，今後將穩定成長。該市場到2019年的年複合成長率(CAGR) 估計約4％。各種急性、慢性疾病的預防，成為主要市場成長要素。維他命D的缺乏症，有可能引起佝僂病和骨質疏鬆症等慢性疾病，及幼兒期的心血管疾病、癌症、氣喘發病，認知障礙，自體免疫等。反過來說，由於頻繁檢查維他命D水準，可預防這些疾病，更加掌握整體醫療費負擔。主要的檢驗項目，有25-羥維生素D檢驗和1, 25-羥基維生素D2種，而25-羥基維生素D檢驗佔整體約76％。
Technavio's market research analyst has estimated this market to show steady growth during the forecast period. The prospect for growth in this market is dependent on factors like the high incidence of vitamin D deficiency among the populace in this region, which results in its slow but moderate CAGR of around 4% by 2019.
The prevention of various acute and chronic diseases is the key driver for the growth of this market. Vitamin D deficiency can lead to various chronic diseases like rickets and osteoporosis, and can also result in cardiovascular diseases, cancer, asthma in infants, cognitive disorders, and autoimmune diseases. The incidence of these diseases can be reduced by frequently testing the vitamin D levels, which in turn would help to reduce the overall healthcare expenditure.
In this market research report, analysts estimate the 25-Hydroxy vitamin D tests segment to be the largest market segment during the forecast period. Currently, this market segment accounts for a share of nearly 76% and is envisaged to retain its dominating hold over the market by 2019. The ability of 25-Hydroxy vitamin D tests to identify bone malformations and softness, bone weakness, or fractures in adults is one of the most significant factors that accounts for its high market share during the forecast period.
The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -
This market is highly competitive and consists of vendors that focus on test development and research. These vendors compete on the basis of price, quality, and breadth of product line, technology, and distribution capabilities to gain maximum prominence in the market.
Key vendors in this market are -
Other prominent vendors analyzed in this market research are Diazyme laboratories, Biokit, ESA Biosciences, Quest Diagnostics Inc., The Vitamin D Company, Tosoh Bioscience Inc., Qualigen Inc., Dade Behring, DIAsource ImmunoAssays S.A, Ortho-Clinical Diagnostics, Piramal Healthcare, Beckman Coulter, and Becton Dickinson.
Upcoming trends such as the augmented adoption of home vitamin D testing kits are rapidly gaining popularity as they are highly cost efficient. Since this market is facing declining reimbursement, patients have to pay out of their pockets to perform these tests. Therefore, in recent times, it has been observed that many patients prefer carrying out such tests at the convenience of their homes as it reduces the overall expenditure.
This report provides a number of factors contributing to the adoption, limitations, and opportunities of the vitamin D testing market in the US. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.